MetaCap

IRulya Therapeutics (IRLA) News

NASDAQ: IRLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.88-0.06 (-0.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IRLA news summary

We found 2 recent headlines mentioning IRulya Therapeutics (IRLA): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, IRLA is down 0.15% at $39.88. The most recent story, "IRulya Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results", was published by GlobeNewswire on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest IRulya Therapeutics headlines

Compare IRLA